NCT05683379View on ClinicalTrials.gov

AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 20, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Duchenne Muscular Dystrophy
Interventions
DIAGNOSTIC_TEST

AAV8 DetectCDx

An in vitro diagnostic assay to detect antibodies to AAV8 in human serum specimens.

Trial Locations (1)

30329

RECRUITING

Rare Disease Research, Atlanta

All Listed Sponsors
lead

REGENXBIO Inc.

INDUSTRY